Study of LY3016859 in Participants With Diabetic Nephropathy

Update Il y a 4 ans
Reference: NCT01774981

Woman and Man

Extract

The purpose of this two-part study is to investigate the safety, tolerability and efficacy of LY3016859 after multiple intravenous (IV) dosing's in participants with diabetic nephropathy (DN). Part A will be dose escalation for safety and tolerability and Part B will evaluate Proteinuria.


Inclusion criteria

  • Diabetic nephropathy

Links